What's in Infectopharm Arzneimittel GmbH's pipeline?

Infectopharm Arzneimittel GmbH has 4 drugs in our index: 0 marketed, 0 filed, 4 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Infectopharm Arzneimittel GmbH's portfolio?

Top competitors by shared drug class: Encube Ethicals Pvt. Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/infectopharm-arzneimittel-gmbh.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Infectopharm Arzneimittel GmbH — Portfolio Competitive Intelligence Brief

Infectopharm Arzneimittel GmbH pipeline: 0 marketed, 0 filed, 4 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 4 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
InfectoScab 5 % Creme	InfectoScab 5 % Creme	phase 3	Scabicide		Dermatology
SanaCutan Basiscreme	SanaCutan Basiscreme	phase 3			Dermatology
Permethrin 10 % Creme	Permethrin 10 % Creme	phase 3	Pyrethroid insecticide	Voltage-gated sodium channels (arthropod nervous system)	Dermatology / Parasitology
Solaraze	Solaraze	phase 3			Other

Therapeutic area mix

Dermatology · 2
Dermatology / Parasitology · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Encube Ethicals Pvt. Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Infectopharm Arzneimittel GmbH:

Cite this brief

Drug Landscape (2026). Infectopharm Arzneimittel GmbH — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/infectopharm-arzneimittel-gmbh. Accessed 2026-05-16.